Načítá se...
Nicotinic Acetylcholine Receptors in Neuropathic and Inflammatory Pain
Nicotinic acetylcholine receptors (nAChRs) are actively being investigated as therapeutic targets for the treatment of pain and inflammation, but despite more than 30 years of research, there are currently no FDA approved analgesics that target these receptors. Much of the initial research effort fo...
Uloženo v:
| Vydáno v: | FEBS Lett |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5899685/ https://ncbi.nlm.nih.gov/pubmed/29030971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1873-3468.12884 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|